The CHM.CN stock price moved from C$0.01 to C$0.05, a 900.00% intraday change on CNQ during market hours on 02 Mar 2026, highlighting extreme volatility in this small-cap healthcare venture. Waverunner Capital Inc. (CHM.CN) is a Canadian microcap with a market cap of C$37,211,650.00 and 744,233,000.00 shares outstanding. The move reflects thin liquidity, a recent corporate rebrand and renewed retail interest. We examine valuation, liquidity, fundamentals, and a model projection to help traders understand risk and opportunity in this high-volume mover

CHM.CN stock: price action and volume snapshot

CHM.CN stock traded at C$0.05 on CNQ after a rise of C$0.05 from a previous close of C$0.01, a 900.00% change recorded at the latest timestamp. Average daily volume is 28,908.00 shares, but real-time volume was not reported; that gap often amplifies large percentage moves in microcaps.

CHM.CN stock: fundamentals and valuation metrics

Waverunner Capital Inc. reports EPS -0.01 and a trailing PE of -5.00, reflecting negative earnings. The company shows a low cash per share of C$0.01 and a book value per share of -0.14, which signals balance-sheet stress relative to larger healthcare peers.

CHM.CN stock: corporate profile and catalysts

Waverunner Capital Inc. (formerly Chemistree Technology) is a North Vancouver venture capital firm focused on early-stage and renewable energy investments; the rebrand in June 2024 is a visible catalyst. The firm targets equity investments between C$0.50 million and C$1.00 million and operates in the healthcare sector on CNQ in Canada.

CHM.CN stock: technical context and volatility risks

The 50-day average price is C$0.04 and the 200-day average price is C$0.05, showing recent price compression. For traders, the microcap float and low liquidity make CHM.CN stock prone to rapid bid-ask swings and sharp reversals.

CHM.CN stock: sector comparison and market drivers

Healthcare peers on the Canadian market have an average PE of 14.27 and weak 1Y performance; Waverunner sits well below sector norms on scale and liquidity. Macro pressure on small healthcare names and capital access for venture investments are key market drivers for CHM.CN stock.

CHM.CN stock: sources and how news links to price

Corporate updates, the June 2024 name change and retail trading flows likely drove the spike in CHM.CN stock; direct company information is at the Waverunner site and historical quotes appear in public data feeds Waverunner website and FinancialModelingPrep company image.

Final Thoughts

Key takeaways on CHM.CN stock: this microcap moved to C$0.05 on CNQ during market hours on 02 Mar 2026, producing a 900.00% headline change that reflects low liquidity rather than a change in underlying earnings. Financials show EPS -0.01, negative book value -0.14 per share and a market cap of C$37,211,650.00, underlining small‑company risk. Meyka AI rates CHM.CN with a score out of 100: 65.04 | Grade: B | Suggestion: HOLD. This grade factors in S&P 500 and sector comparisons, financial growth, key metrics and analyst signals. Meyka AI’s forecast model projects C$0.12 in 12 months from the current C$0.05, an implied upside of 140.00%, with a stressed downside scenario to C$0.03 (-40.00%). Forecasts are model-based projections and not guarantees. Traders should prioritise liquidity checks, position sizing and confirm any corporate news before trading; our platform provides real-time alerts as an AI-powered market analysis platform

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.